We investigated CSF levels of diazepam-binding inhibitor (DBI), a recently discovered neuropeptide that allosterically modulates GABAergic transmission, in various neurodegenerative disorders with dementia (28 patients with Parkinson's disease, 10 with Alzheimer's disease, 7 with Huntington's chorea). We applied a battery of neuropsychological tests to determine the degree of dementia and to exclude the presence of mood alterations. CSF DBI levels were elevated in parkinsonian subjects with dementia and in patients with Alzheimer's disease, but decreased in Huntington's chorea patients. We hypothesize that modifications of CSF DBI levels may be related to a functional or structural alteration of the GABAergic system.

Ferrarese, C., Appollonio, I., Frigo, M., Meregalli, S., Piolti, R., Tamma, F., et al. (1990). Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia. NEUROLOGY, 40(4), 632-635.

Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia

FERRARESE, CARLO;APPOLLONIO, ILDEBRANDO;
1990-04

Abstract

We investigated CSF levels of diazepam-binding inhibitor (DBI), a recently discovered neuropeptide that allosterically modulates GABAergic transmission, in various neurodegenerative disorders with dementia (28 patients with Parkinson's disease, 10 with Alzheimer's disease, 7 with Huntington's chorea). We applied a battery of neuropsychological tests to determine the degree of dementia and to exclude the presence of mood alterations. CSF DBI levels were elevated in parkinsonian subjects with dementia and in patients with Alzheimer's disease, but decreased in Huntington's chorea patients. We hypothesize that modifications of CSF DBI levels may be related to a functional or structural alteration of the GABAergic system.
Articolo in rivista - Articolo scientifico
Scientifica
Reference Values; Humans; Alzheimer Disease; Radioimmunoassay; Chromatography, High Pressure Liquid; Cognition; Diazepam Binding Inhibitor; Parkinson Disease; Adult; Middle Aged; Dementia; Neuropeptides; Female; Huntington Disease; Male
English
Ferrarese, C., Appollonio, I., Frigo, M., Meregalli, S., Piolti, R., Tamma, F., et al. (1990). Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia. NEUROLOGY, 40(4), 632-635.
Ferrarese, C; Appollonio, I; Frigo, M; Meregalli, S; Piolti, R; Tamma, F; Frattola, L
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10281/34920
Citazioni
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 39
Social impact